TNNI3 (Troponin I) Gene Mutation Analysis
The TNNI3 gene, located in the long (q) arm of chromosome 19 at position 13.42 encodes for cardiac troponin I. Cardiac troponin I is an integral inhibitory protein in cardiac muscle that exists as part of a troponin protein complex with troponin C (TnC) and troponin T (TnT). The troponin complex associated with actin and myosin form the contractile element of cardiac and skeletal muscle. The primary function of troponin I, is to serve as an inhibitory subunit of the troponin complex that prevents contraction in the absence of Ca2+ binding to troponin C. The binding of calcium to specific sites on the TnC subunit releases the inhibitory region of TnI from actin, enabling the attachment of the molecular motor protein myosin to allow the cardiac muscle to contract. In the absence of Ca2+, the TnI subunit inhibits the actomyosin ATPase activity. Mutations in this gene are associated with familial hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM) and familial restrictive cardiomyopathy.
Familial HCM is typically inherited as an autosomal dominant heart disorder characterized by unexplained left ventricular (LV) hypertrophy (thickening) associated with non-dilated ventricular chambers. Pathological features include myocardial fiber hypertrophy, disorganized myocardial cells, interstitial fibrosis and thickened intra-myocardial coronary vessels. The majority of HCM patients are asymptomatic. Only about 25% develop symptom such as dyspnea, syncope, collapse, palpitations, and chest pain. The disorder has inter- and intra-familial variability ranging from benign to malignant forms with a high risk of cardiac failure and sudden cardiac death. HCM is the most common cause of sudden cardiac death in young people with the prevalence of 1:500 in the general adult population. The majority of the mutations in HCM are missense, insertion/deletion and frame-shift mutations. Mutation in TNNI3 gene accounts for about 5% of all cases of HCM.
Dilated cardiomyopathy (DCM) is most commonly inherited in an autosomal dominant or X-linked manner. DCM is a disorder characterized by ventricular dilation and impaired systolic function, resulting in congestive heart failure and arrhythmia. DCM is the most common cause of congestive heart failure in young patients, although, conduction impairment, syncope and sudden dealth may also occur. It has a prevalence of approximately 1 per 2,500 in the adult population. Many people with dilated cardiomyopathy have no or only minor symptoms and live a normal life. Other individuals with DCM may develop symptoms such as fatigue, weight loss, fainting, palpitations, chest pain and sudden death. DCM can be categorized as acquired, syndromic, or non-syndromic disorders. Mutations in TNNI3 account for < 2% of DCM.
Restrictive cardiomyopathy (RCM) is a rare cardiac disorder that manifests primarily as an abnormality of diastolic filling, which the result of reduced ventricular compliance or increased stiffness. These changes lead to reduced diastolic volume with preserved systolic function. Symptoms such as failure to thrive, fatigue and fainting may occur in individuals with this disorder.
- As an aid in diagnosis of familial hypertrophic cardiomyopathy and dilated cardiomyopathy
- Carrier screening for relatives and those with the family history
- Prenatal carrier screening for those with the family history
Negative for mutations analyzed (No pathogenic variant or mutation detected)
Whole blood (EDTA).
Stability
- Ambient: 3-5 days
- Refrigerated: 7-14 days
- Frozen: Unacceptable
- BMC Med Genet. 2019;20: 61. [PMID: 30953456]
- Neth Heart J. 2011 Aug; 19(7-8): 344–351. [PMID: 21533915]
- Circ J. 2019;83: 1908-1916. [PMID: 31308319]
- Heart Fail Rev. 2019;24: 439-459. [PMID: 30852773]
- Circ Res. 2009;105: 375-82. [PMID: 19590045]
- Clinical Chemistry, Immunology and Laboratory Quality Control,In: Chapter 8, Cardiac Markers 2014: 127–144. doi:10.1016/b978-0-12-407821-5.00008-5
- Genetics Home Reference. Available at: https://ghr.nlm.nih.gov/gene/TNNI3#